Gene-environment interaction effects on lung function- A genome-wide association study within the framingham heart study

Environmental Health: A Global Access Science Source

Volumn 12, Issue 1, 2013, Pages

  Liao, Shu Yi ^a   Lin, Xihong ^a   Christiani, David C ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HISTONE DEACETYLASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; DUST;

GENOME; GENOTYPE-ENVIRONMENT INTERACTION; LUNAR CRUST; NETWORK ANALYSIS; OCCUPATIONAL EXPOSURE; POLYMORPHISM;

ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; JOB CHARACTERISTICS; LUNG FUNCTION; MALE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; POPULATION EXPOSURE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC38A8 GENE; ADULT; AGED; ANALYSIS; DUST; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; UNITED STATES; VITAL CAPACITY;

ADULT; AGED; BOSTON; DUST; FEMALE; FORCED EXPIRATORY VOLUME; GENE REGULATORY NETWORKS; GENE-ENVIRONMENT INTERACTION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAL CAPACITY;

EID: 84891780839     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-12-101     Document Type: Article

References (60)

1. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G, Am J Respir Crit Care Med 2003 167 787 797 12598220
2. Occupation in chronic obstructive pulmonary disease and chronic bronchitis: an update. Blanc PD, Toren K, Int J Tuberc Lung Dis 2007 11 251 257 17352088 (Pubitemid 46447430)
3. The epidemiology of chronic respiratory disease. Higgins IT, Prev Med 1973 2 14 33 10.1016/0091-7435(73)90005-4 4610551
4. Occupational exposure and 12-year spirometric changes among Paris area workers. Kauffmann F, Drouet D, Lellouch J, Brille D, Br J Ind Med 1982 39 221 232 7093148 (Pubitemid 12045484)
5. Occupational dust exposure and chronic obstructive pulmonary disease. A systematic overview of the evidence. Oxman AD, Muir DC, Shannon HS, Stock SR, Hnizdo E, Lange HJ, Am Rev Respir Dis 1993 148 38 48 10.1164/ajrccm/148.1.38 8317812 (Pubitemid 23187215)
6. Decreased lung function among employees at Norwegian smelters. Johnsen HL, Kongerud J, Hetland SM, Benth JS, Soyseth V, Am J Ind Med 2008 51 296 306 10.1002/ajim.20557 18213638 (Pubitemid 351415342)
7. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Bakke PS, Baste V, Hanoa R, Gulsvik A, Thorax 1991 46 863 870 10.1136/thx.46.12.863 1792631
8. Relations between occupation, smoking, lung function, and incidence and mortality of chronic non-specific lung disease: the Zutphen Study. Heederik D, Kromhout H, Kromhout D, Burema J, Biersteker K, Br J Ind Med 1992 49 299 308 1599867
9. Occupational exposures and chronic respiratory symptoms. A population-based study. Korn RJ, Dockery DW, Speizer FE, Ware JH, Ferris BG Jr, Am Rev Respir Dis 1987 136 298 304 10.1164/ajrccm/136.2.298 3497594 (Pubitemid 18018522)
10. The relation of respiratory symptoms and ventilatory function to moderate occupational exposure in a general population. Results from the French PAARC study of 16,000 adults. Krzyzanowski M, Kauffmann F, Int J Epidemiol 1988 17 397 406 10.1093/ije/17.2.397 3403137
11. Respiratory effects of occupational exposure in a general population sample in north Italy. Viegi G, Prediletto R, Paoletti P, Carrozzi L, Di Pede F, Vellutini M, Di Pede C, Giuntini C, Lebowitz MD, Am Rev Respir Dis 1991 143 510 515 10.1164/ajrccm/143.3.510 2001059
12. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, et al. Am J Respir Crit Care Med 1998 157 1770 1778 10.1164/ajrccm.157.6.9706014 9620904
13. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, Moukhachen H, Venugopal R, Hasimja D, Kao E, et al. Hum Mol Genet 2010 19 526 534 10.1093/hmg/ddp519 19933216
14. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, Franceschini N, van Durme YM, Chen TH, Barr RG, et al. Nat Genet 2010 42 45 52 10.1038/ng.500 20010835
15. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, et al. PLoS Genet 2009 5 1000421 10.1371/journal.pgen.1000421 19300482
16. Genome-wide association study identifies five loci associated with lung function. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, et al. Nat Genet 2010 42 36 44 10.1038/ng.501 20010834
17. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. Wilk JB, Chen TH, Gottlieb DJ, Walter RE, Nagle MW, Brandler BJ, Myers RH, Borecki IB, Silverman EK, Weiss ST, O'Connor GT, PLoS Genet 2009 5 1000429 10.1371/journal.pgen.1000429 19300500
18. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Smolonska J, Wijmenga C, Postma DS, Boezen HM, Am J Respir Crit Care Med 2009 180 618 631 10.1164/rccm.200905-0722OC 19608716
19. Detecting association using epistatic information. Chapman J, Clayton D, Genet Epidemiol 2007 31 894 909 10.1002/gepi.20250 17654599
20. Different genes interact with particulate matter and tobacco smoke exposure in affecting lung function decline in the general population. Curjuric I, Imboden M, Nadif R, Kumar A, Schindler C, Haun M, Kronenberg F, Kunzli N, Phuleria H, Postma DS, et al. PLoS One 2012 7 40175 10.1371/journal.pone.0040175 22792237
21. Genetic and environmental influence on lung function impairment in Swedish twins. Hallberg J, Iliadou A, Anderson M, de Verdier MG, Nihlen U, Dahlback M, Pedersen NL, Higenbottam T, Svartengren M, Respir Res 2010 11 92 10.1186/1465-9921-11-92 20604964
22. Glutathione S-transferase variants and their interaction with smoking on lung function. He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ, Am J Respir Crit Care Med 2004 170 388 394 10.1164/rccm.200312-1763OC 15184197 (Pubitemid 39214612)
23. Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. Hancock DB, Artigas MS, Gharib SA, Henry A, Manichaikul A, Ramasamy A, Loth DW, Imboden M, Koch B, McArdle WL, et al. PLoS Genet 2012 8 1003098 10.1371/journal.pgen.1003098 23284291
24. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, Benjamin EJ, D'Agostino RB Sr, Fox CS, Larson MG, Murabito JM, et al. Am J Epidemiol 2007 165 1328 1335 10.1093/aje/kwm021 17372189 (Pubitemid 47234329)
25. Occupational exposures and the risk of COPD: dusty trades revisited. Blanc PD, Iribarren C, Trupin L, Earnest G, Katz PP, Balmes J, Sidney S, Eisner MD, Thorax 2009 64 6 12 18678700
26. GWAF: an R package for genome-wide association analyses with family data. Chen MH, Yang Q, Bioinformatics 2010 26 580 581 10.1093/bioinformatics/btp710 20040588
27. Comparison of gene expression profiles induced by coarse, fine, and ultrafine particulate matter. Huang YC, Karoly ED, Dailey LA, Schmitt MT, Silbajoris R, Graff DW, Devlin RB, J Toxicol Environ Health A 2011 74 296 312 10.1080/15287394.2010.516238 21240730
28. Secreted modular calcium-binding protein 2 haplotypes are associated with pulmonary function. Wilk JB, Herbert A, Shoemaker CM, Gottlieb DJ, Karamohamed S, Am J Respir Crit Care Med 2007 175 554 560 10.1164/rccm.200601-110OC 17204727 (Pubitemid 46438939)
29. Histone deacetylation: an important mechanism in inflammatory lung diseases. Adcock IM, Ito K, Barnes PJ, COPD 2005 2 445 455 10.1080/ 15412550500346683 17147010 (Pubitemid 43879443)
30. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Barnes PJ, Adcock IM, Ito K, Eur Respir J 2005 25 552 563 10.1183/09031936.05.00117504 15738302 (Pubitemid 40331188)
31. Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD. Chen Y, Huang P, Ai W, Li X, Guo W, Zhang J, Yang J, J Inflamm (Lond) 2012 9 10 10.1186/1476-9255-9-10 22443498
32. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ, N Engl J Med 2005 352 1967 1976 10.1056/NEJMoa041892 15888697 (Pubitemid 40638367)
33. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WD, Moxham J, Hopkinson NS, Polkey MI, Kemp PR, Thorax 2012 67 26 34 10.1136/thoraxjnl-2011-200309 21998125
34. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang W, Zhai G, Zhao JH, Smith AV, Huffman JE, et al. Nat Genet 2011 43 1082 1090 10.1038/ng.941 21946350
35. Emerging roles of PPARs in inflammation and immunity. Daynes RA, Jones DC, Nat Rev Immunol 2002 2 748 759 10.1038/nri912 12360213 (Pubitemid 37328715)
36. Up-regulated membrane and nuclear leukotriene B4 receptors in COPD. Marian E, Baraldo S, Visentin A, Papi A, Saetta M, Fabbri LM, Maestrelli P, Chest 2006 129 1523 1530 10.1378/chest.129.6.1523 16778270 (Pubitemid 43894981)
37. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. Colville-Nash PR, Qureshi SS, Willis D, Willoughby DA, J Immunol 1998 161 978 984 9670978 (Pubitemid 28323565)
38. Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Maestrelli P, Paska C, Saetta M, Turato G, Nowicki Y, Monti S, Formichi B, Miniati M, Fabbri LM, Eur Respir J 2003 21 971 976 10.1183/09031936.03.00098203 12797490 (Pubitemid 36675612)
39. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, et al. Nature 2003 423 506 511 10.1038/nature01621 12724780 (Pubitemid 36648570)
40. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Barnes PJ, Shapiro SD, Pauwels RA, Eur Respir J 2003 22 672 688 10.1183/09031936.03.00040703 14582923 (Pubitemid 37258549)
41. Cellular and molecular characteristics of inflammation in chronic bronchitis. Sun G, Stacey MA, Vittori E, Marini M, Bellini A, Kleimberg J, Mattoli S, Eur J Clin Invest 1998 28 364 372 10.1046/j.1365-2362.1998.00285.x 9650009 (Pubitemid 28261219)
42. Pathogenesis and pathology of COPD. Turato G, Zuin R, Saetta M, Respiration 2001 68 117 128 10.1159/000050478 11287822 (Pubitemid 32260861)
43. Variation of CD8+ T-lymphocytes around the bronchial internal perimeter in chronic bronchitis. Gamble E, Burns W, Zhu J, Ansari T, De Rose V, Kips J, Barnes NC, Jeffery PK, Eur Respir J 2003 22 992 995 10.1183/09031936.03.00115302 14680091 (Pubitemid 37540654)
44. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Silverman EK, Palmer LJ, Mosley JD, Barth M, Senter JM, Brown A, Drazen JM, Kwiatkowski DJ, Chapman HA, Campbell EJ, et al. Am J Hum Genet 2002 70 1229 1239 10.1086/340316 11914989 (Pubitemid 34450572)
45. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Silverman EK, Mosley JD, Palmer LJ, Barth M, Senter JM, Brown A, Drazen JM, Kwiatkowski DJ, Chapman HA, Campbell EJ, et al. Hum Mol Genet 2002 11 623 632 10.1093/hmg/11.6.623 11912177 (Pubitemid 34285133)
46. CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Liu Y, Liang WB, Gao LB, Pan XM, Chen TY, Wang YY, Xue H, Zhang LS, Zhang L, Hum Immunol 2010 71 1141 1146 10.1016/j.humimm. 2010.08.007 20732370
47. CTLA4 gene polymorphisms are associated with chronic bronchitis. Zhu G, Agusti A, Gulsvik A, Bakke P, Coxson H, Lomas DA, Silverman EK, Pillai SG, Eur Respir J 2009 34 598 604 10.1183/09031936.00141808 19386687
48. Identification of loci associated with schizophrenia by genome-wide association and follow-up. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, et al. Nat Genet 2008 40 1053 1055 10.1038/ng.201 18677311
49. Replication of association between schizophrenia and ZNF804A in the Irish Case-control Study of Schizophrenia sample. Riley B, Thiselton D, Maher BS, Bigdeli T, Wormley B, McMichael GO, Fanous AH, Vladimirov V, O'Neill FA, Walsh D, Kendler KS, Mol Psychiatry 2010 15 29 37 10.1038/mp.2009.109 19844207
50. Expanding the range of ZNF804A variants conferring risk of psychosis. Steinberg S, Mors O, Borglum AD, Gustafsson O, Werge T, Mortensen PB, Andreassen OA, Sigurdsson E, Thorgeirsson TE, Bottcher Y, et al. Mol Psychiatry 2011 16 59 66 10.1038/mp.2009.149 20048749
51. Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia. Tan EC, Chong SA, Mahendran R, Tan CH, Teo YY, Schizophr Res 2003 65 61 63 10.1016/S0920-9964(02)00491-7 14623376 (Pubitemid 37410405)
52. Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Town T, Abdullah L, Crawford F, Schinka J, Ordorica PI, Francis E, Hughes P, Duara R, Mullan M, Am J Med Genet 1999 88 458 461 10.1002/(SICI)1096-8628(19991015)88:5<458::AID-AJMG3>3.0.CO;2-S 10490697 (Pubitemid 29485067)
53. The mu-opioid receptor gene and smoking initiation and nicotine dependence. Zhang L, Kendler KS, Chen X, Behav Brain Funct 2006 2 28 10.1186/1744-9081-2-28 16887046 (Pubitemid 44314679)
54. Psychiatric aspects of chronic lung disease. Jain A, Lolak S, Curr Psychiatry Rep 2009 11 219 225 10.1007/s11920-009-0034-9 19470284
55. Physical illness and schizophrenia: a review of the literature. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N, Acta Psychiatr Scand 2007 116 317 333 10.1111/j.1600-0447.2007.01095.x 17919153 (Pubitemid 47537428)
56. Nicotine use in patients with schizophrenia evaluated by the Fagerstrom Tolerance Questionnaire: a descriptive analysis from a Brazilian sample. Chaves L, Shirakawa I, Rev Bras Psiquiatr 2008 30 350 352 10.1590/S1516- 44462008005000014 19142411
57. Pulmonary disease among inpatient decedents: Impact of schizophrenia. Copeland LA, Mortensen EM, Zeber JE, Pugh MJ, Restrepo MI, Dalack GW, Prog Neuropsychopharmacol Biol Psychiatry 2007 31 720 726 10.1016/j.pnpbp.2007.01.008 17292522 (Pubitemid 46467052)
58. Healthy worker effect in a longitudinal study of one-second forced expiratory volume (FEV1) and chronic exposure to granite dust. Eisen EA, Wegman DH, Louis TA, Smith TJ, Peters JM, Int J Epidemiol 1995 24 1154 1161 10.1093/ije/24.6.1154 8824857
59. A review of the healthy worker effect in occupational epidemiology. Li CY, Sung FC, Occup Med (Lond) 1999 49 225 229 10.1093/occmed/49.4.225 10474913 (Pubitemid 29370959)
60. Occupational Epidemiology Boca Raton: CRC Press, Monson R, 1990